Nainital News Flash

Zeyi’s Official Inauguration in Shenzhen Dapeng New District, “Tian Nian Ark Plan” Launched, Opening a New Chapter in Cancer Prevention and Treatment

Zeyi’s Official Inauguration in Shenzhen Dapeng New District, “Tian Nian Ark Plan” Launched, Opening a New Chapter in Cancer Prevention and Treatment

September 19
22:00 2023

On September 16th, the 2023 Cell and Gene Industry Exchange Conference kicked off in the Dapeng New District of Shenzhen. On the same day, the inauguration ceremony of Shenzhen Zeyi Cell Therapy Group (hereinafter referred to as “Shenzhen Zeyi”) was held. At the same time, Shenzhen Zeyi, in collaboration with multiple Nobel laureates, academicians, and domestic and international top scientists and medical experts, jointly initiated the “Tian Nian Ark Plan”.

Guided by the Shenzhen Science, Technology, and Innovation Commission and the Shenzhen Dapeng New District Management Commission, the conference was hosted by Shenzhen Zeyi Cell Therapy Group and jointly organized by the China Health Promotion Foundation, Shenzhen Dapeng New District Bureau for Organization and Human Resources, Shenzhen Dapeng New District Bureau for Science, Technology, Innovation, and Economic Services, Shenzhen Dapeng New District Bureau for Education and Health, and Shenzhen Dapeng New District Industrial Investment Group Co., Ltd. and co-organized by the Shanghai Wu Mengchao Medical Science Foundation. Government officials, authoritative academicians, renowned industry experts and scholars, and industry leaders were invited to attend the conference, including Nobel laureates in chemistry Arieh Warshel and Michael Levitt, who made presentations on cancer prevention and treatment. The conference was also attended by industry elites from all over the country.

A new star in the full industry chain platform of cell therapy lands in the Dapeng New District

Shenzhen Zeyi Cell Therapy Group has been officially inaugurated

At the opening ceremony, leaders of the Shenzhen Science, Technology, and Innovation Commission and Shenzhen Dapeng New District Management Commission, Vice Chairman and Secretary-General of the China Health Promotion Foundation Xi Lusuo, and President of Shenzhen Zeyi Cell Therapy Group Bai Zongke delivered speeches. Then, a highly anticipated event officially began: the leaders solemnly and warmly unveiled the inauguration ceremony of Shenzhen Zeyi and the Shenzhen Bio-Home Zeyi Cell Therapy Project. The guests present witnessed this “Chinese moment” of cell therapy.

The inauguration of the Shenzhen Bio-Home Zeyi Cell Therapy Project

It is understood that Shenzhen Zeyi is a full industry chain platform consisting of a diversified range of entities such as a cell therapy research institute, a top science and technology innovation center in collaboration with Nobel laureates, testing facilities, the largest cell cryopreservation bank in the Guangdong-Hong Kong-Macao Greater Bay Area, and Zeyi clinics. It is committed to promoting the rapid development of cell therapy in the Greater Bay Area and providing innovative solutions in areas such as cancer prevention and treatment.

Bai Zongke, President of Shenzhen Zeyi Cell Therapy Group, delivered a speech.

It is reported that in the implementation of the “20+8” strategic emerging industries and future industry clusters in Shenzhen, Dapeng New District has been actively laying out industry clusters such as biomedicine, healthcare, synthetic biology, cells, and genes, and pushing forward the development of the Pingshan-Dapeng Greater Bay Area life and health innovation demonstration zone with high standards. As the first cell therapy hospital in the Greater Bay Area, Shenzhen Zeyi will undoubtedly further drive its development in cell and gene therapy and base itself in the Greater Bay Area to lead the cell therapy industry in China.

Cell therapy, which Shenzhen Zeyi specializes in, is an emerging medical approach. It has broken through the limitations of traditional surgery and drug treatment, providing a completely new treatment approach and path for diseases such as cancer. In recent years, with a burst of excellent clinical data, the effectiveness of cell therapy has gained global consensus. Regarding Shenzhen Zeyi’s future plans, President Bai Zongke said at the event, “Going forward, the Group will gather strength, adhere to high standards, provide excellent services, and establish an international first-class cancer prevention and treatment center.”

Carrying on the Mission: “Tian Nian Ark Plan” released

Cell Therapy: Enabling people to live healthily to a ripe old age

According to statistics, the number of new cancer cases in people under 50 was 1.82 million in 2019, a 79% increase from 1990, and the number of new cancer cases and cancer-related deaths for people under 50 worldwide is expected to continue to rise by 2030.

To fulfill the mission of conquering cancer, Shenzhen Zeyi joined hands with multiple Nobel laureates, academicians, and domestic and international top scientists and medical experts at the conference, to launch the “Tian Nian Ark Plan”, a plan to enable people to live a healthy life to a ripe old age within 20 years through precise cell therapy techniques.

The Tian Nian Ark Plan was released

A short film introduced at the conference revealed that the “Tian Nian Ark Plan” originated from Academician Wu Mengchao’s layout of cell therapy in 2000. The release of the plan coincides with the significant day of Academician Wu’s 101st birthday, representing the continuation of his wish. Previously, under his leadership, China made rapid advancements in cell therapy. In just 23 years, China’s cell technology achieved a leap in progress, with research projects comparable to the United States, far surpassing Japan and Europe. To drive this plan forward, Shenzhen Zeyi is using emerging cell and gene technologies to assist more people in early cancer prevention to keep them away from tumors.

In recent years, Shenzhen Zeyi has conducted multidimensional and in-depth systematic research on the fundamentals, applications, and clinical transformation in cell therapy, collaborating with well-known domestic and international institutions. Through strong collaboration and complementary advantages, they have explored key common scientific issues in cell therapy, developed new technologies and products for cell therapy, nurtured professional talents in this field, and boosted the scientific and standardized development of the cell therapy industry, contributing to the health and sustainable development of the industry.

Shenzhen welcomes the “national team” for cancer prevention and treatment

Embarking on a golden era of health lead by cell therapy

After the opening ceremony, a cell and gene industry conference and lectures on cancer prevention and treatment were carried out. Many authoritative academicians, renowned industry experts and scholars, as well as industry leaders, engaged with attendees in profound discussions about the application, development, opportunities, and challenges of cell therapy in cancer prevention and treatment. The splendid academic presentations resembled a feast of knowledge that greatly benefited the attendees.

Nobel laureates in chemistry Arieh Warshel and Michael Levitt

Foreign academician of Russian Academy of Engineering Wu Jiong and academician of the Chinese Academy of Sciences Chen Runsheng

Currently, cell medicine has become one of China’s development strategies and an inevitable direction for medical science and technology development. The global cell therapy industry is entering a golden period of development. The rapid advancement of the cell and gene industry relies on policy support, market demand, and corporate innovation vitality. With the successful conclusion of the 2023 Cell and Gene Industry Exchange Conference in the Dapeng New District in Shenzhen, it is believed that the cell and gene industry will play a more significant role in the biopharmaceutical industry, bringing more benefits to human health.

We expect that Shenzhen Zeyi will leverage its cutting-edge cell technology and outstanding medical expert team to establish a world-class cancer prevention and treatment center, and lead the development of China’s cell therapy industry to provide brand-new cancer prevention and treatment solutions for more families.

Media Contact
Company Name: ShenZhen ZeYi Cell Therapy Group Co. Limited
Contact Person: Xiaotong Zheng
Email: Send Email
Address:5 Building, Baguang Biological Garden, Dapeng New District
City: Shenzhen
Country: China
Website: http://www.zeyi.net.cn